Affinity DataIC50: 140nMAssay Description:Inhibition of C3bi-AP binding to CR3 derived from human PMNMore data for this Ligand-Target Pair
Affinity DataIC50: 330nMAssay Description:Inhibition of C3bi-AP binding to CR3 derived from human PMNMore data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:Antagonist activity at CR3 in carboxyfluorescein diacetate succiminidyl ester-labeled human PMN assessed as inhibition of TNF/PMA-stimulated adhesion...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:Antagonist activity at CR3 in carboxyfluorescein diacetate succiminidyl ester-labeled human PMN assessed as inhibition of TNF/PMA-stimulated adhesion...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of Mac-1 integrin (alphaM-beta2)More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of Mac-1 interaction with ICAMMore data for this Ligand-Target Pair
Affinity DataEC50: 1.86E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
Affinity DataEC50: >5.00E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
Affinity DataEC50: 4.09E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
Affinity DataEC50: >5.00E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
Affinity DataEC50: 3.56E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
Affinity DataEC50: 4.04E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
Affinity DataEC50: 2.23E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
Affinity DataEC50: 1.80E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
Affinity DataEC50: 1.05E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
Affinity DataEC50: 2.32E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
Affinity DataEC50: 1.36E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
Affinity DataEC50: >5.00E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair